Valeant Pharmaceuticals International Inc (NYSE:VRX)

24.27
Delayed Data
As of Jun 22
 -0.45 / -1.82%
Today’s Change
10.94
Today|||52-Week Range
27.79
+16.79%
Year-to-Date

Five Year Financial Summary

Total Revenue

Cash & Short Term Investments

Cash From Operations

All Currency in US Dollars4 Year
Trend

2014

2015

2016

2017
AssetsCash322.6M597.3M542.0M797.0M
 
 
 
 
 
Short Term Investment Cash-277.7M279.9M-55.0M255.0M
 
 
 
 
 
Cash & Short Term Investments322.6M613.3M543.0M797.0M
 
 
 
 
 
 
ReceivablesReceivables2.1B2.7B2.5B2.1B
 
 
 
 
 
 
InventoriesInventories950.6M1.3B1.1B1.0B
 
 
 
 
 
 
Current AssetsPrepaid Expenses--20.0M8.0M7.0M
 
 
 
 
Other Current Assets844.1M930.4M948.0M764.0M
 
 
 
 
 
Current Assets4.2B5.5B5.1B4.7B
 
 
 
 
 
 
Total AssetsProperty, Plant and Equipment - Gross2.3B2.6B2.5B2.8B
 
 
 
 
 
Depreciation-977.9M-1.2B-1.2B-1.4B
 
 
 
 
 
Intangible Assets20.6B41.6B34.7B30.8B
 
 
 
 
 
Other Assets20.8B41.9B37.0B30.9B
 
 
 
 
 
Total Assets26.4B49.0B43.5B37.5B
 
 
 
 
 
 
LiabilitiesAccounts Payable398.0M433.7M324.0M365.0M
 
 
 
 
 
Short Term Debt7.1M838.5M7.0M209.0M
 
 
 
 
 
Accrued Expenses62.0M364.3M12.0M--
 
 
 
 
Other Current Liabilities2.0B3.6B2.9B3.2B
 
 
 
 
 
Other Liabilities2.7B5.3B3.6B4.3B
 
 
 
 
 
 
Total LiabilitiesLong Term Debt15.3B30.3B29.8B25.2B
 
 
 
 
 
Deferred Taxes-2.2B-5.7B-5.3B-747.0M
 
 
 
 
 
Other Liabilities466.7M1.1B1.0B870.0M
 
 
 
 
 
Total Liabilities20.9B42.9B40.3B31.6B
 
 
 
 
 
 
EquityMinority Interest-1.3M-3.9M-1.0M0.00
 
 
 
 
Preferred Stock0.00--0.000.00--
Common Equity5.3B5.9B3.2B5.8B
 
 
 
 
 
Total Shareholder Equity5.3B5.9B3.2B5.8B
 
 
 
 
 
 
Share InformationCommon Shares Outstanding334.4M342.9M347.8M348.7M
 
 
 
 
 
 
Addtl. Info.No data currently available for this section.